Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Pickles

Showing results (91-100 of 139) with videos related to

Pageof 14
Sort By:
Cancer|March 20, 2002
Testosterone recovery following prolonged adjuvant androgen ablation for prostate carcinomaTom Pickles, Alex Agranovich, Eric Berthelet, et al.
The Journal of Urology|August 23, 2017
Long-Term Prostate Specific Antigen Stability and Predictive Factors of Failure after Permanent Seed Prostate BrachytherapyAudrey Tetreault-Laflamme, Juanita Crook, Jeremy Hamm, et al.
Brachytherapy|February 17, 2015
Effect of aging and long-term erectile function after iodine-125 prostate brachytherapyMira Keyes, Tom Pickles, Juanita Crook, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 9, 2013
A criterion-based audit of the technical quality of external beam radiotherapy for prostate cancerMichael Brundage, Brita Danielson, Robert Pearcey, et al.
The Canadian Journal of Urology|September 6, 2007
What is the optimal duration of androgen deprivation therapy in prostate cancer patients presenting with prostate-specific antigen levels > 20 ng/ml?Eric Berthelet, Tom Pickles, Pauline T Truong, et al.
European Urology|December 3, 2014
Active surveillance for prostate cancer: a systematic review of clinicopathologic variables and biomarkers for risk stratificationStacy Loeb, Sophie M Bruinsma, Joseph Nicholson, et al.
Cancer|January 3, 2013
Population-based 10-year oncologic outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancerW James Morris, Mira Keyes, Ingrid Spadinger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 4, 2013
Population-based validation of a policy change to use long-term androgen deprivation therapy for cT3-4 prostate cancer: impact of the EORTC22863 and RTOG 85-31 and 92-02 trialsEric Tran, Matthew Paquette, Tom Pickles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Impact of providing audiotapes of primary adjuvant treatment consultations to women with breast cancer: a multisite, randomized, controlled trialThomas F Hack, Tom Pickles, Barry D Bultz, et al.
Cancer|June 22, 2010
Long-term outcomes for patients with limited stage follicular lymphoma: involved regional radiotherapy versus involved node radiotherapyBelinda A Campbell, Nick Voss, Ryan Woods, et al.
Pageof 14

Showing results (91-100 of 139) with videos related to

Sort By:
Pageof 14
Cancer|March 20, 2002
Testosterone recovery following prolonged adjuvant androgen ablation for prostate carcinomaTom Pickles, Alex Agranovich, Eric Berthelet, et al.
The Journal of Urology|August 23, 2017
Long-Term Prostate Specific Antigen Stability and Predictive Factors of Failure after Permanent Seed Prostate BrachytherapyAudrey Tetreault-Laflamme, Juanita Crook, Jeremy Hamm, et al.
Brachytherapy|February 17, 2015
Effect of aging and long-term erectile function after iodine-125 prostate brachytherapyMira Keyes, Tom Pickles, Juanita Crook, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 9, 2013
A criterion-based audit of the technical quality of external beam radiotherapy for prostate cancerMichael Brundage, Brita Danielson, Robert Pearcey, et al.
The Canadian Journal of Urology|September 6, 2007
What is the optimal duration of androgen deprivation therapy in prostate cancer patients presenting with prostate-specific antigen levels > 20 ng/ml?Eric Berthelet, Tom Pickles, Pauline T Truong, et al.
European Urology|December 3, 2014
Active surveillance for prostate cancer: a systematic review of clinicopathologic variables and biomarkers for risk stratificationStacy Loeb, Sophie M Bruinsma, Joseph Nicholson, et al.
Cancer|January 3, 2013
Population-based 10-year oncologic outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancerW James Morris, Mira Keyes, Ingrid Spadinger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 4, 2013
Population-based validation of a policy change to use long-term androgen deprivation therapy for cT3-4 prostate cancer: impact of the EORTC22863 and RTOG 85-31 and 92-02 trialsEric Tran, Matthew Paquette, Tom Pickles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Impact of providing audiotapes of primary adjuvant treatment consultations to women with breast cancer: a multisite, randomized, controlled trialThomas F Hack, Tom Pickles, Barry D Bultz, et al.
Cancer|June 22, 2010
Long-term outcomes for patients with limited stage follicular lymphoma: involved regional radiotherapy versus involved node radiotherapyBelinda A Campbell, Nick Voss, Ryan Woods, et al.
Pageof 14